Blood Disorder Program: Prevention, Surveillance, and Research

To work with State health agencies and other public and private and nonprofit organizations in planning, development, implementation, coordination, or evaluation of programs or other activities related to improved blood disorders.

To provide a national, State or local focus for the prevention
of conditions in persons with blood disorders; to employ epidemiological methods to set priorities, build capacity and direct health promotion interventions for persons with blood disorders; to expand public health training opportunities through fellowships to introduce geneticists, epidemiologists, and clinicians to public health practice through education, training and career-enhancing experiences.

Agency - Department of Health and Human Services

The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.




Program Accomplishments

Not Applicable.

Uses and Use Restrictions

Funds may be used to strengthen, to expand, to build upon or to enhance surveillance, health promotion, education and training, prevention/intervention activities that contribute to the mission and activities of the Division of Blood Disorders.

Funds may be used to improve and strengthen State and local public health infrastructure by providing technical assistance to other appropriate health agencies, organizations, special groups or coalitions.

Funds may be used to support capacity building, program planning, development, implementation, evaluation, and surveillance for blood disorders outcomes, including related health promotion, education and training, and prevention/intervention.

Funds may also be used to coordinate the dissemination of prevention information to the general public, target populations and among state and local agencies and public and private sector organizations in the United States.

Funds may not be used for direct curative or rehabilitative services.

Eligibility Requirements

Applicant Eligibility

N/A.

Beneficiary Eligibility

N/A.

Credentials/Documentation

No Credentials or documentation are required. This program is excluded from coverage under OMB Circular No. A-87.

Aplication and Award Process

Preapplication Coordination

Preapplication coordination is not applicable.

Environmental impact information is not required for this program.

This program is excluded from coverage under E.O.

12372.

Application Procedures

OMB Circular No. A-102 applies to this program. OMB Circular No. A-110 applies to this program. OMB Circular No. A-102 applies to this program. OMS Circular No. A-110 applies to this program. Information on the submission of applications may be obtained from the Grants Management Officer, Grants Management Branch, Procurement and Grants Office, Centers for Disease Control and Prevention, 2920 Brandywine Road, Room 3000, Atlanta, GA 30341. Telephone: (770) 488-2700.

Funding announcements will be posted on www.grants.gov. Forms and instructions are available in an interactive format on the Grants.gov web site, at the following Internet address: www.grants.gov. Submit the final application using the www.grants.gov website.

Award Procedures

After review and approval, a Notice of Award from the CDC Procurement and Grants Office (PGO) is prepared and signed by an authorized Grants Management Officer and mailed to the recipient officer identified in the application, along with appropriate notification to the public. The initial award provides funds for first budget period (usually 12 months) and Notice of Award indicates support recommended for the remainder of project period, allocation of Federal funds by budget categories, and special conditions, if any.

Cooperative agreement awards and grants, competitive and single eligibility, are determined by an internal objective committee review process at CDC, including peer reviews for research activities. Awards will be based on evaluation criteria set forth in the respective Funding Opportunity Announcements, the availability of funds, and such other significant factors as deemed necessary and appropriate by CDC.

Deadlines

Contact the headquarters or regional office, as appropriate, for application deadlines.

Authorization

Public Health Service Act Sections 301, 301(a), 311, and 317C (42 U.S.C. Sections 241, 241(a), 237b-4, 243, 247-4, and 247b-4, as amended.

Range of Approval/Disapproval Time

From 90 to 120 days. After review and approval, a Notice of Award from the CDC Procurement and Grants Office (PGO) is prepared and signed by an authorized Grants Management Officer and mailed to the recipient officer identified in the application, along with appropriate notification to the public. The initial award provides funds for first budget period (usually 12 months) and Notice of Award indicates support recommended for the remainder of project period, allocation of Federal funds by budget categories, and special conditions, if any.

Cooperative agreement awards and grants, competitive and single eligibility, are determined by an internal objective committee review process at CDC, including peer reviews for research activities. Awards will be based on evaluation criteria set forth in the respective Funding Opportunity Announcements, the availability of funds, and such other significant factors as deemed necessary and appropriate by CDC.

Appeals

Not Applicable.

Renewals

From 1 to 5 years with 12 month budget periods.

Assistance Considerations

Formula and Matching Requirements

Statutory formulas are not applicable to this program.
Matching requirements are not applicable to this program.
MOE requirements are not applicable to this program.

Length and Time Phasing of Assistance

Awards vary from 3-5 years. Method of awarding/releasing assistance: lump sum.

Post Assistance Requirements

Reports

Federal Financial Reports.

No cash reports are required.

90 days after each budget period.

No expenditure reports are required.

No performance monitoring is required.

Audits

No audits are required for this program.

Records

No Data Available.

Financial Information

Account Identification

75-0958-1-1-550.

Obigations

(Cooperative Agreements) FY 12 $0; FY 13 est $12,000,000; and FY 14 est $12,000,000 - No funds were obligated in 2012.

Range and Average of Financial Assistance

Fy 14 rand is dependent upon funding avalability. Award amounts range from $5,0000 to 4,000,000.

Regulations, Guidelines, and Literature

Regulations governing this program are published under 42 CFR Part 51b. Guidelines are available in the application kit.

Information Contacts

Regional or Local Office

None.

Headquarters Office

Shelia Jones 1600 Clifton Rd, Atlanta, Georgia 30043 Email: sjones3@cdc.gov Phone: 3

Criteria for Selecting Proposals

Not Applicable.


Here, five companies are marking their imprints to implement their corporate philanthropy goals. These companies are: Patagonia, Fuse Corps, Dow Corning, Warner Bros., and VeryNice.






More Federal Domestic Assistance Programs


Construction Support | Migratory Bird Monitoring, Assessment and Conservation | Environmental Education Grants | Academic Exchange Programs - Special Academic Exchange Programs | Aid To Tribal Governments |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders